Latest BAROnova Inc. Stories
BAROnova, Inc. announced today the closing of its Series B financing of $7.5 million, led by a strategic investment from Allergan, Inc., a global multi-specialty healthcare company with a leading portfolio in obesity intervention devices. Series A investors, Arboretum Ventures, Highland Capital Partners and ONSET Ventures, filled out the round. The proceeds will be used to continue the clinical development of BAROnova's non-surgical, non-pharmacologic TransPyloric Shuttle (TPS)...
- A spider.
- Figuratively, a peevish, testy, ill-natured person.